KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Free Cash Flow (2016 - 2026)

Medtronic's Free Cash Flow history spans 13 years, with the latest figure at $2.3 billion for Q1 2026.

  • For Q1 2026, Free Cash Flow rose 9.73% year-over-year to $2.3 billion; the TTM value through Jan 2026 reached $5.4 billion, down 1.04%, while the annual FY2025 figure was $5.2 billion, 0.29% changed from the prior year.
  • Free Cash Flow for Q1 2026 was $2.3 billion at Medtronic, up from $457.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $2.4 billion in Q2 2024 and bottomed at $200.0 million in Q4 2023.
  • The 5-year median for Free Cash Flow is $1.2 billion (2023), against an average of $1.3 billion.
  • The largest annual shift saw Free Cash Flow tumbled 66.61% in 2023 before it skyrocketed 177.0% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at $599.0 million in 2022, then crashed by 66.61% to $200.0 million in 2023, then surged by 177.0% to $554.0 million in 2024, then fell by 17.51% to $457.0 million in 2025, then soared by 403.28% to $2.3 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Free Cash Flow are $2.3 billion (Q1 2026), $457.0 million (Q4 2025), and $584.0 million (Q3 2025).